Illumina (ILMN) Cash from Financing Activities (2009 - 2026)
Illumina (ILMN) posted quarterly Cash from Financing Activities of -$129.0 million for Q2 2026, up 65.23% year-over-year from -$78.1 million in Q2 2025, and up 48.61% on a QoQ basis from -$251.0 million in Q1 2026.
Illumina (ILMN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Illumina has reported Cash from Financing Activities for 18 years, with the latest figure at -$129.0 million in Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at -$129.0 million, up 65.23% year-over-year; the trailing twelve-month figure through Jun 2026 was -$558.0 million (up 40.95% YoY), and the FY2025 annual result was -$744.0 million, down 30.53% from the prior year.
- Cash from Financing Activities improved to -$129.0 million in Q2 2026, from -$251.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $922.0 million in Q1 2023 and troughed at -$707.0 million in Q4 2023.
- A 5-year average of -$122.6 million and a median of -$122.0 million in 2025 frame the typical range for Cash from Financing Activities.
- The largest YoY upside for Cash from Financing Activities was 107.4% in 2024 against a maximum downside of 7433.33% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $21.0 million in 2022, then plunged by 228.57% to -$27.0 million in 2023, then sank by 74.07% to -$47.0 million in 2024, then tumbled by 34.04% to -$63.0 million in 2025, then tumbled by 104.76% to -$129.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$129.0 million in Q2 2026, -$251.0 million in Q1 2026, and -$63.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | -229.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -129.00 Mn |
| Jun 28, 2026 | -129.00 Mn |
| Mar 29, 2026 | -251.00 Mn |
| Mar 29, 2026 | -251.00 Mn |
| Dec 28, 2025 | -63.00 Mn |
| Dec 28, 2025 | -63.00 Mn |
| Sep 28, 2025 | -115.00 Mn |
| Sep 28, 2025 | -115.00 Mn |
| Jun 29, 2025 | -371.00 Mn |
| Jun 29, 2025 | -371.00 Mn |
| Mar 30, 2025 | -195.00 Mn |
| Mar 30, 2025 | -195.00 Mn |
| Dec 29, 2024 | -47.00 Mn |
| Dec 29, 2024 | -47.00 Mn |
| Sep 29, 2024 | -332.00 Mn |
| Sep 29, 2024 | -332.00 Mn |
| Jun 30, 2024 | -226.00 Mn |
| Jun 30, 2024 | -226.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Mar 31, 2024 | 35.00 Mn |